Placebo Inhaler
Placebo Inhaler is a pharmaceutical drug with 9 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
1
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
88.9%
8 of 9 finished
11.1%
1 ended early
0
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029)
A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma
Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis
Nicotine Replacement for Smoking Cessation During Pregnancy
The Effects of Inhaled Glucocorticoids on the Postmenopausal Skeleton
Clinical Trials (9)
The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029)
A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma
Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis
Nicotine Replacement for Smoking Cessation During Pregnancy
The Effects of Inhaled Glucocorticoids on the Postmenopausal Skeleton
Corrected QT (QTc) Study With Flucticasone Furoate and GW642444
Characterization of Placebo Responses in Stable Asthma
Pharmacodynamic Study to Compare Acute Effects of Dihydroergotamine Mesylate (DHE) on Pulmonary Arterial Pressure
Smoking Reduction or Cessation With Nicotine Replacement Therapy
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9